$1.11 Billion is the total value of First Light Asset Management, LLC's 74 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 10.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RETA | Sell | REATA PHARMACEUTICALS INC | $144,283,494 | +84.1% | 1,586,928 | -23.1% | 12.99% | +78.6% |
| PRTA | Sell | PROTHENA CORP PLC | $73,246,313 | -20.8% | 1,511,168 | -1.6% | 6.60% | -23.2% |
| MODN | Sell | MODEL N INC | $62,042,435 | -33.0% | 1,853,673 | -18.8% | 5.59% | -35.0% |
| ATRC | Buy | ATRICURE INC | $60,477,913 | -6.2% | 1,459,057 | +0.5% | 5.44% | -9.0% |
| NEO | Buy | NEOGENOMICS INC | $46,988,859 | +89.6% | 2,698,958 | +0.6% | 4.23% | +84.0% |
| ATEC | Buy | ALPHATEC HLDGS INC | $45,928,350 | +27.1% | 2,944,125 | +0.6% | 4.14% | +23.3% |
| OFIX | New | ORTHOFIX MED INC | $44,403,764 | – | 2,650,971 | +100.0% | 4.00% | – |
| KRTX | Buy | KARUNA THERAPEUTICS INC | $44,261,127 | +36.8% | 243,675 | +48.0% | 3.98% | +32.7% |
| SIBN | Buy | SI-BONE INC | $41,586,550 | +45.2% | 2,114,212 | +0.4% | 3.74% | +40.9% |
| PLRX | Buy | PLIANT THERAPEUTICS INC | $37,914,416 | +85.4% | 1,425,354 | +34.7% | 3.41% | +79.9% |
| Buy | PARAGON 28 INC | $34,787,619 | +47.2% | 2,037,939 | +64.8% | 3.13% | +42.8% | |
| PFMT | Buy | PERFORMANT FINL CORP | $27,916,377 | +4.7% | 8,210,699 | +11.1% | 2.51% | +1.6% |
| HALO | Sell | HALOZYME THERAPEUTICS INC | $26,282,587 | -50.0% | 688,206 | -25.4% | 2.37% | -51.5% |
| KRMD | Sell | KORU MEDICAL SYSTEMS INC | $26,127,358 | +15.5% | 6,191,317 | -2.3% | 2.35% | +12.0% |
| CRNX | Buy | CRINETICS PHARMACEUTICALS IN | $26,003,148 | +6.9% | 1,619,125 | +21.8% | 2.34% | +3.7% |
| TMDX | Buy | TRANSMEDICS GROUP INC | $25,590,076 | +56.4% | 337,912 | +27.5% | 2.30% | +51.7% |
| KROS | Buy | KEROS THERAPEUTICS INC | $25,362,263 | -10.8% | 593,964 | +0.3% | 2.28% | -13.5% |
| TNDM | Buy | TANDEM DIABETES CARE INC | $23,926,803 | -9.2% | 589,185 | +0.5% | 2.15% | -11.9% |
| HCAT | Buy | HEALTH CATALYST INC | $23,110,299 | +87.1% | 1,980,317 | +70.4% | 2.08% | +81.6% |
| BLU | Buy | BELLUS HEALTH INC NEW | $21,746,830 | +12.2% | 3,020,393 | +28.1% | 1.96% | +8.9% |
| OMCL | Sell | OMNICELL COM | $19,566,973 | +12.8% | 333,509 | -3.1% | 1.76% | +9.4% |
| AXGN | Sell | AXOGEN INC | $18,343,357 | -22.5% | 1,941,096 | -18.2% | 1.65% | -24.8% |
| AXNX | Sell | AXONICS INC | $16,872,134 | -13.1% | 309,240 | -0.4% | 1.52% | -15.7% |
| KRYS | Sell | KRYSTAL BIOTECH INC | $15,690,159 | -58.2% | 195,980 | -58.6% | 1.41% | -59.4% |
| BCYC | Buy | BICYCLE THERAPEUTICS PLC | $14,874,707 | -27.8% | 699,328 | +0.4% | 1.34% | -30.0% |
| OPRX | Buy | OPTIMIZERX CORP | $14,789,921 | +143.7% | 1,010,931 | +179.8% | 1.33% | +136.6% |
| CUTR | Buy | CUTERA INC | $13,460,282 | -46.3% | 569,868 | +0.5% | 1.21% | -47.9% |
| KIDS | Sell | ORTHOPEDIATRICS CORP | $13,356,934 | +11.1% | 301,579 | -0.4% | 1.20% | +7.8% |
| INSM | Buy | INSMED INC | $12,802,555 | -14.4% | 750,883 | +0.3% | 1.15% | -17.0% |
| TCMD | New | TACTILE SYS TECHNOLOGY INC | $11,494,000 | – | 700,000 | +100.0% | 1.04% | – |
| REPH | Buy | SOCIETAL CDMO INC | $10,611,075 | -16.9% | 8,916,870 | +4.0% | 0.96% | -19.4% |
| XENE | New | XENON PHARMACEUTICALS INC | $10,001,301 | – | 279,444 | +100.0% | 0.90% | – |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL IN | $9,454,658 | -12.9% | 235,777 | +0.6% | 0.85% | -15.6% |
| SONENDO INC | $8,371,238 | -29.3% | 4,185,619 | 0.0% | 0.75% | -31.4% | ||
| Sell | MAXCYTE INC | $6,752,899 | -9.4% | 1,364,222 | -0.1% | 0.61% | -12.1% | |
| GMAB | Sell | GENMAB A/S | $6,042,544 | -11.0% | 160,025 | -0.1% | 0.54% | -13.7% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $5,978,510 | -52.2% | 61,482 | -49.2% | 0.54% | -53.7% |
| PFE | Sell | PFIZER INC | $5,775,123 | -20.5% | 141,547 | -0.2% | 0.52% | -22.8% |
| ABCM | Buy | ABCAM PLC | $5,110,910 | -13.5% | 379,711 | +0.0% | 0.46% | -16.1% |
| GH | Buy | GUARDANT HEALTH INC | $4,801,567 | -13.8% | 204,845 | +0.0% | 0.43% | -16.4% |
| MIRO | Buy | MIROMATRIX MED INC | $3,754,222 | +134.8% | 2,234,656 | +318.0% | 0.34% | +128.4% |
| CSTL | Buy | CASTLE BIOSCIENCES INC | $3,671,961 | -3.5% | 161,618 | +0.0% | 0.33% | -6.2% |
| New | STEVANATO GROUP S P A | $2,987,720 | – | 115,356 | +100.0% | 0.27% | – | |
| Sell | AKUMIN INC | $2,406,859 | -6.1% | 3,539,498 | -0.7% | 0.22% | -8.8% | |
| SLP | Sell | SIMULATIONS PLUS INC | $1,568,792 | +20.0% | 35,703 | -0.1% | 0.14% | +16.5% |
| HUM | HUMANA INC | $431,088 | -5.2% | 888 | 0.0% | 0.04% | -7.1% | |
| IART | INTEGRA LIFESCIENCES HLDGS C | $416,854 | +2.4% | 7,261 | 0.0% | 0.04% | 0.0% | |
| TAK | TAKEDA PHARMACEUTICAL CO LTD | $422,382 | +5.6% | 25,630 | 0.0% | 0.04% | +2.7% | |
| SNN | SMITH & NEPHEW PLC | $421,748 | +3.8% | 15,111 | 0.0% | 0.04% | 0.0% | |
| SNY | SANOFI | $419,633 | +12.4% | 7,711 | 0.0% | 0.04% | +8.6% | |
| BAYRY | BAYER AG SPONSORED ADR | $405,817 | +23.9% | 25,475 | 0.0% | 0.04% | +23.3% | |
| ANTM | ELEVANCE HEALTH INC | $407,392 | -10.4% | 886 | 0.0% | 0.04% | -11.9% | |
| FMS | FRESENIUS MED CARE AG&CO KGA | $414,357 | +30.1% | 19,490 | 0.0% | 0.04% | +23.3% | |
| ENOVIS CORPORATION | $385,288 | -0.1% | 7,203 | 0.0% | 0.04% | -2.8% | ||
| NVS | NOVARTIS AG | $379,316 | +1.4% | 4,123 | 0.0% | 0.03% | -2.9% | |
| QUIDELORTHO CORP | $379,256 | +4.0% | 4,257 | 0.0% | 0.03% | 0.0% | ||
| GILD | GILEAD SCIENCES INC | $375,522 | -3.4% | 4,526 | 0.0% | 0.03% | -5.6% | |
| EXEL | EXELIXIS INC | $358,017 | +21.0% | 18,445 | 0.0% | 0.03% | +18.5% | |
| GSK PLC | $357,864 | +1.3% | 10,058 | 0.0% | 0.03% | -3.0% | ||
| CNC | CENTENE CORP DEL | $348,982 | -22.9% | 5,521 | 0.0% | 0.03% | -26.2% | |
| MDT | MEDTRONIC PLC | $337,637 | +3.7% | 4,188 | 0.0% | 0.03% | 0.0% | |
| JNJ | JOHNSON & JOHNSON | $334,955 | -12.3% | 2,161 | 0.0% | 0.03% | -14.3% | |
| XRAY | DENTSPLY SIRONA INC | $323,196 | +23.4% | 8,228 | 0.0% | 0.03% | +20.8% | |
| VTRS | VIATRIS INC | $317,556 | -13.6% | 33,010 | 0.0% | 0.03% | -14.7% | |
| QGEN | QIAGEN NV | $317,468 | -7.9% | 6,912 | 0.0% | 0.03% | -9.4% | |
| HCA | HCA HEALTHCARE INC | $305,869 | +9.9% | 1,160 | 0.0% | 0.03% | +7.7% | |
| AVTR | AVANTOR INC | $308,559 | +0.2% | 14,596 | 0.0% | 0.03% | -3.4% | |
| UTHR | UNITED THERAPEUTICS CORP DEL | $301,226 | -19.5% | 1,345 | 0.0% | 0.03% | -22.9% | |
| BIIB | BIOGEN INC | $304,721 | +0.4% | 1,096 | 0.0% | 0.03% | -3.6% | |
| PKI | PERKINELMER INC | $296,237 | -5.0% | 2,223 | 0.0% | 0.03% | -6.9% | |
| OGN | ORGANON & CO | $299,080 | -15.8% | 12,716 | 0.0% | 0.03% | -18.2% | |
| LH | LABORATORY CORP AMER HLDGS | $279,434 | -2.6% | 1,218 | 0.0% | 0.02% | -7.4% | |
| PDCO | PATTERSON COS INC | $247,997 | -4.5% | 9,264 | 0.0% | 0.02% | -8.3% | |
| SYNH | SYNEOS HEALTH INC | $204,316 | -2.9% | 5,736 | 0.0% | 0.02% | -10.0% | |
| IWO | Exit | ISHARES RUSSELL 2000 GROWTH ETF | $0 | – | -3,422 | -100.0% | -0.07% | – |
| BVS | Exit | BIOVENTUS INC | $0 | – | -1,376,536 | -100.0% | -0.33% | – |
| HZNP | Exit | HORIZON PHARMA PLC | $0 | – | -137,077 | -100.0% | -1.45% | – |
| SPNE | Exit | SEASPINE HOLDINGS CORP | $0 | – | -6,877,650 | -100.0% | -5.33% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ATRICURE INC | 40 | Q3 2023 | 9.7% |
| NEOGENOMICS INC | 40 | Q3 2023 | 10.6% |
| SANOFI-SYNTHELABO | 40 | Q3 2023 | 1.9% |
| JOHNSON & JOHNSON | 40 | Q3 2023 | 0.3% |
| PFIZER INC | 39 | Q2 2023 | 0.9% |
| BIOMARIN PHARMACEUTICAL INC | 36 | Q3 2023 | 1.6% |
| OMNICELL INC | 33 | Q3 2023 | 7.7% |
| QUIDEL CORP | 33 | Q4 2021 | 3.7% |
| NOVARTIS AG-SPONSORED ADR | 33 | Q3 2023 | 0.4% |
| MODEL N INC | 30 | Q3 2023 | 9.0% |
View First Light Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| REATA PHARMACEUTICALS INC | May 15, 2023 | 1,290,193 | 3.9% |
| Axogen, Inc. | February 03, 2023 | 1,942,270 | 4.6% |
| MODEL N, INC. | February 03, 2023 | 1,845,134 | 4.9% |
| MEI Pharma, Inc.Sold out | May 31, 2022 | 0 | 0.0% |
| PROTHENA CORP PUBLIC LTD CO | March 01, 2022 | 1,805,038 | 3.9% |
| Intersect ENT, Inc. | February 14, 2022 | 1,375,210 | 4.1% |
| SeaSpine Holdings Corp | February 14, 2022 | 6,847,707 | 18.8% |
| Oxford Immunotec Global PLCSold out | February 10, 2021 | 0 | 0.0% |
| ENDOLOGIX INC /DE/ | February 14, 2020 | 816,236 | 4.6% |
| Nuvectra CorpSold out | February 14, 2020 | 0 | 0.0% |
View First Light Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-09 |
| 4 | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
View First Light Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.